Search Results

There are 11723 results for: content related to: Estrogen protects bone by inducing Fas ligand in osteoblasts to regulate osteoclast survival

  1. Pre-existing fas ligand (FasL) in cancer cells elicits tumor-specific protective immunity, but delayed induction of FasL expression after inoculation facilitates tumor formation

    Molecular Carcinogenesis

    Volume 52, Issue 9, September 2013, Pages: 705–714, Hsiao-Ying Chiu, Guang-Huan Sun, Shiow-Yi Chen, Hsiao-Hsien Wang, Ming-Yi Ho, Chia-Yi Chu, Wan-Lin Wu, Ren-Shiang Jhou, Yi-Lin Tsai, Rui-Ting Huang, Kuang-Hui Sun and Shye-Jye Tang

    Version of Record online : 9 APR 2012, DOI: 10.1002/mc.21909

  2. Index to Divisions of al-Ghazālī's Often-Cited Published Works

    The Muslim World

    Volume 102, Issue 1, January 2012, Pages: 70–200, M. Afifi al-Akiti

    Version of Record online : 22 DEC 2011, DOI: 10.1111/j.1478-1913.2011.01374.x

  3. You have free access to this content
    Listeria monocytogenes virulence proteins induce surface expression of Fas ligand on T lymphocytes

    Molecular Microbiology

    Volume 51, Issue 5, March 2004, Pages: 1483–1492, Lauren A. Zenewicz, Jason A. Skinner, Howard Goldfine and Hao Shen

    Version of Record online : 4 FEB 2004, DOI: 10.1111/j.1365-2958.2003.03931.x

  4. A vision of cell death: Fas ligand and immune privilege 10 years later

    Immunological Reviews

    Volume 213, Issue 1, October 2006, Pages: 228–238, Thomas A. Ferguson and Thomas S. Griffith

    Version of Record online : 14 SEP 2006, DOI: 10.1111/j.1600-065X.2006.00430.x

  5. You have free access to this content
    Combination of molecular mimicry and aberrant autoantigen expression is important for development of anti-Fas ligand autoantibodies in patients with systemic lupus erythematosus

    Clinical & Experimental Immunology

    Volume 129, Issue 2, August 2002, Pages: 359–369, S. MIHARA, N. SUZUKI, Y. TAKEBA, K. SOEJIMA and S. YAMAMOTO

    Version of Record online : 5 AUG 2002, DOI: 10.1046/j.1365-2249.2002.01812.x

  6. You have free access to this content
    The regulation of FasL expression during activation-induced cell death (AICD)


    Volume 103, Issue 4, August 2001, Pages: 426–434, Thang Nguyen and John Russell

    Version of Record online : 21 DEC 2001, DOI: 10.1046/j.1365-2567.2001.01264.x

  7. You have free access to this content
    A proteomic screen reveals novel Fas ligand interacting proteins within nervous system Schwann cells

    FEBS Letters

    Volume 581, Issue 23, September 18, 2007, Pages: 4455–4462, Peter B. Thornhill, Jason B. Cohn, Gillian Drury, William L. Stanford, Alan Bernstein and Julie Desbarats

    Version of Record online : 22 AUG 2007, DOI: 10.1016/j.febslet.2007.08.025

  8. You have free access to this content
    Expression of FasL in squamous cell carcinomas of the cervix and cervical intraepithelial neoplasia and its role in tumor escape mechanism


    Volume 106, Issue 5, 1 March 2006, Pages: 1065–1077, Ramy Ibrahim, Helen Frederickson, Allyson Parr, Yvona Ward, Joel Moncur and Samir N. Khleif

    Version of Record online : 2 FEB 2006, DOI: 10.1002/cncr.21697

  9. You have free access to this content
    Fas Ligand as a Tool for Immunosuppression and Generation of Immune Tolerance


    Volume 22, Issue 6, November 2004, Pages: 908–924, Osnat Bohana-Kashtan and Curt I. Civin

    Version of Record online : 1 NOV 2004, DOI: 10.1634/stemcells.22-6-908

  10. You have free access to this content
    Palmitoylation is required for efficient Fas cell death signaling

    The EMBO Journal

    Volume 26, Issue 1, January 10, 2007, Pages: 209–220, Krittalak Chakrabandhu, Zoltán Hérincs, Sébastien Huault, Britta Dost, Ling Peng, Fabien Conchonaud, Didier Marguet, Hai-Tao He and Anne-Odile Hueber

    Version of Record online : 7 DEC 2006, DOI: 10.1038/sj.emboj.7601456

  11. You have free access to this content
    ERα signaling regulates MMP3 expression to induce FasL cleavage and osteoclast apoptosis

    Journal of Bone and Mineral Research

    Volume 28, Issue 2, February 2013, Pages: 283–290, Alejandro J Garcia, Colton Tom, Miriam Guemes, Gloria Polanco, Maria E Mayorga, Korinna Wend, Gustavo A Miranda-Carboni and Susan A Krum

    Version of Record online : 15 JAN 2013, DOI: 10.1002/jbmr.1747

  12. You have free access to this content
    Renal Tubular Epithelial Cell Self-Injury Through Fas/Fas Ligand Interaction Promotes Renal Allograft Injury

    American Journal of Transplantation

    Volume 4, Issue 10, October 2004, Pages: 1583–1594, Caigan Du, Jifu Jiang, Qiunong Guan, Ziqin Yin, Mark Masterson, Anwar Parbtani, Robert Zhong and Anthony M. Jevnikar

    Version of Record online : 2 JUL 2004, DOI: 10.1111/j.1600-6143.2004.00552.x

  13. Fas ligand and tumour counter-attack in colorectal cancer stratified according to microsatellite instability status

    The Journal of Pathology

    Volume 201, Issue 1, September 2003, Pages: 46–54, Julie M Michael-Robinson, Nirmala Pandeya, Margaret C Cummings, Michael D Walsh, Joanne P Young, Barbara A Leggett, David M Purdie, Jeremy R Jass and Graham L Radford-Smith

    Version of Record online : 30 MAY 2003, DOI: 10.1002/path.1406

  14. You have free access to this content
    The role of Fas ligand and transforming growth factor β in tumor progression


    Volume 100, Issue 11, 1 June 2004, Pages: 2281–2291, Ryungsa Kim, Manabu Emi, Kazuaki Tanabe, Yoko Uchida and Tetsuya Toge

    Version of Record online : 28 APR 2004, DOI: 10.1002/cncr.20270

  15. You have free access to this content
    Balanced effect of PACAP and FasL on granule cell death during cerebellar development: a morphological, functional and behavioural characterization

    Journal of Neurochemistry

    Volume 113, Issue 2, April 2010, Pages: 329–340, Aurélie Allais, Delphine Burel, Vincent Roy, Sébastien Arthaud, Ludovic Galas, Emma Rachel Isaac, Arnaud Desfeux, Bénédicte Parent, Alain Fournier, Pierre Chapillon, Nancy McKeown Sherwood, Hubert Vaudry and Bruno José Gonzalez

    Version of Record online : 24 DEC 2009, DOI: 10.1111/j.1471-4159.2009.06555.x

  16. miR-21 represses FasL in microglia and protects against microglia-mediated neuronal cell death following hypoxia/ischemia


    Volume 60, Issue 12, December 2012, Pages: 1888–1895, Li Zhang, Lian-Yan Dong, Ya-Jian Li, Zhen Hong and Wen-Shi Wei

    Version of Record online : 20 AUG 2012, DOI: 10.1002/glia.22404

  17. You have free access to this content
    Gemcitabine sensitizes lung cancer cells to Fas/FasL system-mediated killing


    Volume 141, Issue 2, February 2014, Pages: 242–255, Liboria Siena, Elisabetta Pace, Maria Ferraro, Caterina Di Sano, Mario Melis, Mirella Profita, Mario Spatafora and Mark Gjomarkaj

    Version of Record online : 9 JAN 2014, DOI: 10.1111/imm.12190

  18. You have free access to this content
    Fas and Fas ligand expression in tumor cells and in vascular smooth-muscle cells of colonic and renal carcinomas

    International Journal of Cancer

    Volume 81, Issue 5, 31 May 1999, Pages: 772–778, Lucie Peduto Eberl, Louis Guillou, Emilia Saraga, Michael Schröter, Lars E. French, Jürg Tschopp and Lucienne Juillerat-Jeanneret

    Version of Record online : 8 NOV 1999, DOI: 10.1002/(SICI)1097-0215(19990531)81:5<772::AID-IJC18>3.0.CO;2-S

  19. Cloning and potential utility of porcine Fas ligand: overexpression in porcine endothelial cells protects them from attack by human cytolytic cells


    Volume 9, Issue 6, November 2002, Pages: 410–421, Shigeru Tsuyuki, Mari Kono and Eda T. Bloom

    Version of Record online : 4 OCT 2002, DOI: 10.1034/j.1399-3089.2002.01114.x

  20. Human Fas-ligand expression on porcine endothelial cells does not protect against xenogeneic natural killer cytotoxicity


    Volume 11, Issue 1, January 2004, Pages: 43–52, Ulrike B. Matter-Reissmann, Kai-Christian Sonntag, Urs O. Gilli, Christian Leguern, Mårten K. J. Schneider and Jörg D. Seebach

    Version of Record online : 16 DEC 2003, DOI: 10.1111/j.1399-3089.2004.00081.x